We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.79B
AUM Growth
+$579M
Cap. Flow
+$109M
Cap. Flow %
1.4%
Top 10 Hldgs %
71.8%
Holding
138
New
7
Increased
44
Reduced
52
Closed
7

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$349M
2
PG icon
Procter & Gamble
PG
+$148M
3
KO icon
Coca-Cola
KO
+$22.7M
4
HDB icon
HDFC Bank
HDB
+$9.79M
5
PFE icon
Pfizer
PFE
+$5.65M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$216M
2
C icon
Citigroup
C
+$118M
3
V icon
Visa
V
+$63.9M
4
DXCM icon
DexCom
DXCM
+$5.47M
5
KTWO
K2M Group Holdings, Inc
KTWO
+$5.35M

Sector Composition

Rank Sector Weight
1 Financials 26.45%
2 Consumer Discretionary 18.43%
3 Healthcare 14.45%
4 Communication Services 13.53%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
51
DELISTED
Exact Sciences
EXAS
$7.31M 0.09%
92,572
-20,127
-18% -$1.31M
TSM icon
52
TSMC
TSM
$2.1T
$6.98M 0.09%
157,969
-10,421
-6% -$432K
HZNP
53
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.88M 0.09%
351,349
-64,136
-15% -$1.22M
ALKS icon
54
Alkermes
ALKS
$8.22B
$6.85M 0.09%
161,466
– –
DVAX
55
DELISTED
Dynavax Technologies
DVAX
$6.77M 0.09%
545,715
-249,032
-31% -$3.37M
AERI
56
DELISTED
Aerie Pharmaceuticals
AERI
$6.66M 0.09%
108,266
-2,572
-2% -$165K
PTLA
57
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.96M 0.08%
223,682
+76,095
+52% +$2.48M
TVRD
58
Tvardi Therapeutics
TVRD
$19.7M
$5.93M 0.08%
6,873
-1,181
-15% -$853K
GWPH
59
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.89M 0.08%
34,088
+2,230
+7% +$322K
AIMT
60
DELISTED
Aimmune Therapeutics
AIMT
$5.68M 0.07%
208,182
-38,567
-16% -$1.09M
HRTX icon
61
Heron Therapeutics
HRTX
$93.9M
$5.64M 0.07%
178,283
-32,729
-16% -$1.22M
HOLX
62
DELISTED
Hologic
HOLX
$5.43M 0.07%
132,631
+43,754
+49% +$1.77M
LHCG
63
DELISTED
LHC Group LLC
LHCG
$5.25M 0.07%
51,016
-7,651
-13% -$716K
DXCM icon
64
DexCom
DXCM
$31.5B
$5.22M 0.07%
146,040
-176,372
-55% -$5.47M
NKTR icon
65
Nektar Therapeutics
NKTR
$2.39B
$4.94M 0.06%
+5,398
New +$4.61M
PRTK
66
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4.93M 0.06%
508,282
-27,846
-5% -$281K
INSM icon
67
Insmed
INSM
$21.4B
$4.87M 0.06%
240,642
-170,312
-41% -$3.85M
XENT
68
DELISTED
Intersect ENT, Inc
XENT
$4.81M 0.06%
167,333
-2,102
-1% -$63.1K
COLL icon
69
Collegium Pharmaceutical
COLL
$1.15B
$4.71M 0.06%
319,750
+171,506
+116% +$3.04M
IOVA icon
70
Iovance Biotherapeutics
IOVA
$1.82B
$4.51M 0.06%
400,603
+15,157
+4% +$215K
DERM
71
DELISTED
Dermira, Inc.
DERM
$4.45M 0.06%
407,771
-73,899
-15% -$745K
ITCI
72
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.31M 0.06%
198,703
+25,047
+14% +$524K
GKOS icon
73
Glaukos
GKOS
$9.83B
$4.3M 0.06%
66,307
-10,894
-14% -$534K
CHRS icon
74
Coherus Oncology
CHRS
$217M
$3.76M 0.05%
227,896
-39,261
-15% -$696K
PODD icon
75
Insulet
PODD
$11.5B
$3.73M 0.05%
35,215
+5,720
+19% +$536K
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

C WorldWide Group's Q3 2018 Portfolio in Review

As of Q3 2018, C WorldWide Group held 138 positions worth $7.79B, up 8% from $7.21B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

C WorldWide Group's Q3 2018 filing shows 7 new, 44 increased, 52 reduced and 7 closed positions. Its largest new stake was ExxonMobil: 4,273,004 shares worth $363M. The largest sale was Philip Morris, an estimated $216M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q3 2018 buy was ExxonMobil: 4,273,004 shares worth $363M.
  • C WorldWide Group added most to Procter & Gamble in Q3 2018, an estimated $148M increase.
  • C WorldWide Group's biggest Q3 2018 reduction was Citigroup, cutting an estimated $118M.
  • C WorldWide Group fully exited Philip Morris in Q3 2018, selling an estimated $216M.
  • C WorldWide Group's ten largest holdings make up 72% of its $7.79B portfolio in Q3 2018.
  • C WorldWide Group opened 7 new positions and closed 7 in Q3 2018.
  • C WorldWide Group's portfolio value rose 8% quarter-over-quarter to $7.79B.

Based on C WorldWide Group's 13F filing for Q3 2018, filed 5 Nov 2018.